Menu

To set up a press or media interview with this expert contact:

Brandie Campbell

Email: bcampbell@phi.org

Biography

Anne Kelsey Lamb, MPH, is the Director of Regional Asthma Management and Prevention (RAMP), a project of the Public Health Institute. Serving as the Director since 2002, Ms. Lamb provides overall strategic guidance in working toward the organization’s vision and mission, ensuring a highly effective organization and innovative, successful programs. Emphasizing both prevention and management, Ms. Lamb leads RAMP in building capacity, creating linkages, and mobilizing networks to advance policy and systems change targeting the root causes of asthma disparities. Through both government and foundation grants, RAMP works to: advance comprehensive policies on housing quality, affordability and tenant protections; shape policies to reduce air pollution in inequitably burdened communities; and increase access to prevention-oriented services within health care, and advance workforce development for asthma professionals.

Prior to leading RAMP, Ms. Lamb worked at Kaiser Permanente, the National Tay-Sachs & Allied Diseases Association, the Massachusetts Department of Public Health Genetics Program, and the Prevention Center of Boston. Ms. Lamb received a Master’s degree in Public Health from the University of Michigan.

“When we think about the recommendations that experts make during wildfire smoke events, a lot of those simply aren’t feasible for low-income residents,” explains PHI’s Anne Kelsey Lamb, highlighting how social determinants like substandard housing, limited transportation options and cost of air filtration units contribute to increased smoke exposures for low-income communities.

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient

Close

New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to PHI.org